I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Fischbach, Cathie
12
results:
Search for persons
X
Format
Online (12)
Mediatypes
Articles (Online) (7)
OpenAccess-fulltext (5)
Sorted by: Relevance
Sorted by: Year
?
1
Outcomes of non-small cell lung cancer patients with non-V6..:
Lazar, Raluca
;
Fischbach, Cathie
;
Schott, Roland
.
Frontiers in Oncology. 14 (2024) - p. , 2024
Link:
https://doi.org/10.3389/..
?
2
Anaplastic Lymphoma Kinase Inhibitor-Induced Neutropenia: A..:
Moinard-Butot, Fabien
;
Nannini, Simon
;
Fischbach, Cathie
...
Cancers. 15 (2023) 20 - p. 4940 , 2023
Link:
https://doi.org/10.3390/..
?
3
Consequences of Discontinuing a 4/6 Cyclin D-Dependent Kina..:
Martin, Sophie
;
Pflumio, Carole
;
Trensz, Philippe
...
Clinical Breast Cancer. 23 (2023) 1 - p. 32-37 , 2023
Link:
https://doi.org/10.1016/..
?
4
Weekly Paclitaxel, Carboplatin, and Cetuximab as First-Line..:
Carinato, Hélène
;
Burgy, Mickaël
;
Ferry, Régine
...
Frontiers in Oncology. 11 (2021) - p. , 2021
Link:
https://doi.org/10.3389/..
?
5
Persistent taxane‐induced neuropathy in elderly patients tr..:
Pabst, Lucile
;
Velten, Michel
;
Fischbach, Cathie
...
The Breast Journal. 26 (2020) 12 - p. 2376-2382 , 2020
Link:
https://doi.org/10.1111/..
?
6
Evolution of Physical Status From Diagnosis to the End of F..:
Mallard, Joris
;
Hucteau, Elyse
;
Schott, Roland
...
Frontiers in Oncology. 10 (2020) - p. , 2020
Link:
https://doi.org/10.3389/..
?
7
Fulvestrant and palbociclib combination in heavily pretreat..:
Herrscher, Hugo
;
Velten, Michel
;
Leblanc, Julie
...
Breast Cancer Research and Treatment. 179 (2019) 2 - p. 371-376 , 2019
Link:
https://doi.org/10.1007/..
?
8
Weekly Paclitaxel, Carboplatin, and Cetuximab as First-Line..:
Carinato, Hélène
;
Burgy, Mickaël
;
Ferry, Régine
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580328/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
9
Evolution of Physical Status From Diagnosis to the End of F..:
Mallard, Joris
;
Hucteau, Elyse
;
Schott, Roland
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438727/. , 2020
Link:
http://www.ncbi.nlm.nih...
?
10
Anaplastic Lymphoma Kinase Inhibitor-Induced Neutropenia: A..:
Fabien Moinard-Butot
;
Simon Nannini
;
Cathie Fischbach
...
https://www.mdpi.com/2072-6694/15/20/4940. , 2023
Link:
https://doi.org/10.3390/..
?
11
Weekly Paclitaxel, Carboplatin, and Cetuximab as First-Line..:
Hélène Carinato
;
Mickaël Burgy
;
Régine Ferry
...
https://www.frontiersin.org/articles/10.3389/fonc.2021.714551/full. , 2021
Link:
https://doi.org/10.3389/..
?
12
Evolution of Physical Status From Diagnosis to the End of F..:
Joris Mallard
;
Elyse Hucteau
;
Roland Schott
...
https://www.frontiersin.org/article/10.3389/fonc.2020.01304/full. , 2020
Link:
https://doi.org/10.3389/..
1-12
